Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis

Gennaro Giustino , Usman Baber , Olga Salianski , Samantha Sartori , Gregg W. Stone , Martin B. Leon , Melissa Aquino , Giulio G. Stefanini , P. Gabriel Steg , Stephan Windecker , Monica O’ Donoghue , William Wijns , Patrick W. Serruys , Marco Valgimigli , Marie-Claude Morice , Edoardo Camenzind , Giora Weisz , Pieter C. Smits , David Kandzari , Clemens Von Birgelen , George D. Dangas , Jin Y. Cha , Soren Galatius , Raban V. Jeger , Takeshi Kimura , Ghada W. Mikhail , Dipti Itchhaporia , Laxmi Mehta , Rebecca Ortega , Hyo-Soo Kim , Adnan Kastrati , Philippe Genereux , Alaide Chieffo and Roxana Mehran

Background: The safety and efficacy of new-generation drug-eluting stents (DES) in women with multiple atherothrombotic risk (ATR) factors is unclear.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model

Smita Sihag , Michael S. Haas , Karen M. Kim , J. Luis Guerrero , Jonathan Beaudoin , Elisabeth M. Alicot , Franziska Schuerpf , James D. Gottschall , Robyn J. Puro , Joren C. Madsen , David H. Sachs , Walter Newman , Michael C. Carroll and James S. Allan

Background: Acute coronary syndrome is the leading cause of mortality worldwide. However, treatment of acute coronary occlusion inevitably results in ischemia-reperfusion injury. Circulating natural IgM has been shown to play a significant role in mouse models of ischemia-reperfusion injury. A highly conserved self-antigen, nonmuscle myosin heavy chain II, has been identified as a target of pathogenic IgM. We hypothesized that a monoclonal antibody (m21G6) directed against nonmuscle myosin heavy chain II may inhibit IgM binding and reduce injury in a preclinical model of myocardial infarction. Thus, our objective was to evaluate the efficacy of intravenous m21G6 treatment in limiting infarct expansion, troponin release, and left ventricular dysfunction in a swine myocardial infarction model.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions

Carey Kimmelstiel, Duane Pinto, Herbert D. Aronow, Andrew R. Weintraub, George Dangas, Weihong Fan, Jayne Prats, Efthymios N. Deliargyris and Barry T. Katzen

Background: Peripheral vascular interventions are increasingly preferred for the treatment of patients with symptomatic peripheral arterial disease because they are associated with similar clinical outcomes and lower morbidity than open surgical procedures. The objective of this study was to assess the comparative effectiveness of procedural anticoagulation with bivalirudin compared with unfractionated heparin in patients undergoing peripheral vascular interventions.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents

Taek Kyu Park, Young Bin Song, Joonghyun Ahn, K.C. Carriere, Joo-Yong Hahn, Jeong Hoon Yang, Seung-Hyuk Choi, Jin-Ho Choi, Sang Hoon Lee and Hyeon-Cheol Gwon

Background: The use of dual-antiplatelet therapy (DAPT) exceeding 12 months may increase a bleeding risk despite a lower risk of ischemic events. There is no study to compare clinical outcomes in patients treated with a single-antiplatelet drug after DAPT in the era of drug-eluting stents (DES). We sought to investigate the efficacy and safety of clopidogrel versus aspirin monotherapy after 12-month DAPT after DES implantation using an institutional registry.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Efficacy and Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing Percutaneous Coronary Intervention: A Survey and Systematic Review

Matteo Bianco , Alessandro Bernardi , Fabrizio D’Ascenzo , Enrico Cerrato , Pierluigi Omedè , Antonio Montefusco , James J. DiNicolantonio , Giuseppe Biondi Zoccai , Ferdinando Varbella , Giovanni Carini , Claudio Moretti , Roberto Pozzi and Fiorenzo Gaita

Background: The most suitable approach for patients with aspirin hypersensitivity undergoing percutaneous coronary intervention remains to be assessed.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial

Angelo B. Biviano , Tamim Nazif , Jose Dizon , Hasan Garan , Jessica Fleitman , Dua Hassan , Samir Kapadia , Vasilis Babaliaros , Ke Xu , Rupa Parvataneni , Josep Rodes-Cabau , Wilson Y. Szeto , William F. Fearon , Danny Dvir , Todd Dewey , Mathew Williams , Michael J. Mack , John G. Webb , D. Craig Miller , Craig R. Smith , Martin B. Leon and Susheel Kodali

Background: This study sought to evaluate the impact of atrial fibrillation (AF) on clinical outcomes in patients undergoing transcatheter aortic valve replacement.

01 enero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Bioresorbable Scaffolds to Treat Spontaneous Coronary Artery Dissection

Fernando Macaya, Vicente Peral, Mar Alameda, Marcos Pascual, Alfredo Gomez-Jaume, Luis Asmarats, Jaume Maristany, Manuel Ojeda and Armando Bethencourt

Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndromes (ACS), typically affecting female and younger individuals with no underlying atherosclerotic disease. Diagnosis of SCAD has traditionally relied on coronary angiography; however, new imaging modalities, and especially optical coherence tomography (OCT), improve diagnostic accuracy and help management. The optimal treatment strategy remains controversial and may vary from a completely conservative approach to percutaneous or even surgical revascularization, always guided by the clinical scenario and symptoms. When percutaneous coronary intervention is chosen, metal stents are usually implanted on vessels with no significant atherosclerotic lesions. Use of bioresorbable vascular scaffolds (BVS) may have an interesting therapeutic role for these patients because they disappear completely after 2 or 3 years and may allow for a complete functional recovery, which is particularly appealing in SCAD, where spontaneous healing is part of the natural history of this entity. In this sense, we describe 3 documented experiences corresponding to 3 different patients with ACS caused by SCAD from 3 different coronary arteries.

01 febrero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. The Rotterdam Radial Access Research: Ultrasound-Based Radial Artery Evaluation for Diagnostic and Therapeutic Coronary Procedures

Francesco Costa , Maarten A.H. van Leeuwen , Joost Daemen , Roberto Diletti , Floris Kauer , Robert-Jan van Geuns , Jurgen Ligthart , Karen Witberg , Felix Zijlstra , Marco Valgimigli and Nicolas M. Van Mieghem

Background: Radial artery wall might be damaged after cannulation for cardiac catheterization. We investigated structural changes of the radial artery wall after catheterization to understand whether these might predict radial pulsation loss or occlusion and local pain or functional impairment of the upper extremity.

01 febrero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial

Yaling Han , Bo Xu , Kai Xu , Changdong Guan , Quanmin Jing , Qiangsun Zheng , Xueqi Li , Xianxian Zhao , Haichang Wang , Xuezhong Zhao , Xiaoyan Li , Pengfei Yu , Hongyun Zang , Zhifang Wang , Xuebin Cao , Jun Zhang , Wenyue Pang , Jing Li , Yuejin Yang and George D. Dangas

Background: There are no reports on a large-scale randomized trial exploring optimal dual antiplatelet therapy (DAPT) duration after biodegradable polymer sirolimus-eluting stent implantation. We sought to report the outcomes of a randomized substudy of the prospective Evaluate Safety and Effectiveness of the Tivoli DES and the Firebird DES for Treatment of Coronary Revascularization (I-LOVE-IT 2) trial.

01 febrero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients

Konstantinos C. Koskinas, George C.M. Siontis, Raffaele Piccolo, Anna Franzone, Alan Haynes, Julie Rat-Wirtzler, Sigmund Silber, Patrick W. Serruys, Thomas Pilgrim, Lorenz Räber, Dik Heg, Peter Jüni and Stephan Windecker

Background: Diabetes mellitus and angiographic coronary artery disease complexity are intertwined and unfavorably affect prognosis after percutaneous coronary interventions, but their relative impact on long-term outcomes after percutaneous coronary intervention with drug-eluting stents remains controversial. This study determined drug-eluting stents outcomes in relation to diabetic status and coronary artery disease complexity as assessed by the Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) score.

01 marzo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival

Pil Hyung Lee, Seung-Whan Lee, Hee-Soon Park, Se Hun Kang, Byeong Joo Bae, Mineok Chang, Jae-Hyung Roh, Sung-Han Yoon, Jung-Min Ahn, Duk-Woo Park, Soo-Jin Kang, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park and Seung-Jung Park

Objectives: The purpose of this study was to evaluate long-term clinical outcomes after drug-eluting stent–supported percutaneous coronary intervention (PCI) for native coronary total occlusion (CTO).

01 marzo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents

Marlies M. Kok, Liefke C. van der Heijden, Hanim Sen, Peter W. Danse, Marije M. Löwik, Rutger L. Anthonio, J. (Hans) W. Louwerenburg, Frits H.A.F. de Man, Gerard C.M. Linssen, Maarten J. IJzerman, Carine J.M. Doggen, Angela H.E.M. Maas, Roxana Mehran and Clemens von Birgelen

Objectives: This study sought to assess sex differences in chest pain after percutaneous coronary intervention (PCI) with newer generation drug-eluting stents (DES).

01 marzo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions

Alexandre Abizaid, Ricardo A. Costa, Joachim Schofer, John Ormiston, Michael Maeng, Bernhard Witzenbichler, Roberto V. Botelho, J. Ribamar Costa Jr., Daniel Chamié, Andrea S. Abizaid, Juliana P. Castro, Lynn Morrison, Sara Toyloy, Vinayak Bhat, John Yan and Stefan Verheye

Objectives: This study sought to report the late multimodality imaging and clinical outcomes of the novel poly-L-lactic-acid–based DESolve novolimus-eluting bioresorbable coronary scaffold for the treatment of de novo coronary lesions.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.